Evidence map›Paper›PMID 25939383›Full record

ArticleMolecular and cellular biology2015

Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.

Ozlem Kulak, Hua Chen, Brody Holohan, Xiaofeng Wu, Huawei He, Dominika Borek, Zbyszek Otwinowski, Kiyoshi Yamaguchi, Lauren A Garofalo, Zhiqiang Ma and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Exceptional reactivity of the bridgehead amine on bicyclo[1.1.1]pentane.ARKIVOC : free online journal of organic chemistry · 2023
    Article
  7. Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-LinkedMolecules (Basel, Switzerland) · 2022
    Article
  8. The Role of Telomerase in Breast Cancer's Response to Therapy.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Review
  11. Wnt/β-catenin signaling in cancers and targeted therapies.Signal transduction and targeted therapy · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. 3,4,5-Tri-Frontiers in cell and developmental biology · 2020
    Article
  19. Review
  20. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity.Cellular and molecular life sciences : CMLS · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ozlem KulakDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hua ChenDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Brody HolohanDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Xiaofeng WuDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Huawei HeDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Dominika BorekDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Zbyszek OtwinowskiDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kiyoshi YamaguchiDivision of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Lauren A GarofaloDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Zhiqiang MaDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Woodring WrightDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Chuo ChenDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Jerry W ShayDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Xuewu ZhangDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA Xuewu.zhang@utsouthwestern.edu Lawrence.lum@utsouthwestern.edu.
Lawrence LumDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Xuewu.zhang@utsouthwestern.edu Lawrence.lum@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Cell Biology Research Improvements and RenovationsC06RR030414 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI FITZ, JOHN GREGORY · 2010 to 2010
$15.0M
X-RAY CRYSTALLOGRAPHY OF MACROMOLECULESR01GM053163 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI MINOR, WLADEK, OTWINOWSKI, ZBYSZEK · 1996 to 2014
$6.3M
Chemical disruption of Wnt-mediated signal transductionR01CA168761 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI KIM, JAMES · 2013 to 2017
$2.3M
NCI NIH HHS 5P30 CA142543NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS P50-CA70907NCI NIH HHS R01 CA168761NCI NIH HHS R01CA168761NCRR NIH HHS C06 RR030414NCRR NIH HHS C06 RR30414NIGMS NIH HHS R01 GM053163NIGMS NIH HHS R01GM053163
6 · The paper itself

Abstract

Maintenance of chromosomal ends (telomeres) directly contributes to cancer cell immortalization. The telomere protection enzymes belonging to the tankyrase (Tnks) subfamily of poly(ADP-ribose) polymerases (PARPs) have recently been shown to also control transcriptional response to secreted Wnt signaling molecules. Whereas Tnks inhibitors are currently being developed as therapeutic agents for targeting Wnt-related cancers and as modulators of Wnt signaling in tissue-engineering agendas, their impact on telomere length maintenance remains unclear. Here, we leveraged a collection of Wnt pathway inhibitors with previously unassigned mechanisms of action to identify novel pharmacophores supporting Tnks inhibition. A multifaceted experimental approach that included structural, biochemical, and cell biological analyses revealed two distinct chemotypes with selectivity for Tnks enzymes. Using these reagents, we revealed that Tnks inhibition rapidly induces DNA damage at telomeres and telomeric shortening upon long-term chemical exposure in cultured cells. On the other hand, inhibitors of the Wnt acyltransferase Porcupine (Porcn) elicited neither effect. Thus, Tnks inhibitors impact telomere length maintenance independently of their affects on Wnt/β-catenin signaling. We discuss the implications of these findings for anticancer and regenerative medicine agendas dependent upon chemical inhibitors of Wnt/β-catenin signaling.

Indexed as

beta CateninBlotting, WesternCell Line, TumorCrystallography, X-RayEnzyme InhibitorsHEK293 CellsHeterocyclic Compounds, 3-RingHumansImidesModels, MolecularMolecular StructureProtein BindingProtein Structure, TertiaryQuinolinesRNA InterferenceSmall Molecule Librariesbeta CateninEnzyme InhibitorsHeterocyclic Compounds, 3-RingImidesIWR-1 compoundQuinolinesSmall Molecule LibrariesTankyrasesTNKS protein, humanXAV939

Identifiers

PMID25939383
PMCPMC4475917
OpenAlexW1951102280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.